Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.50
+6.73 (3.15%)
AAPL  257.71
+4.21 (1.66%)
AMD  230.79
+9.26 (4.18%)
BAC  51.85
+1.57 (3.13%)
GOOG  314.83
+10.90 (3.59%)
META  611.00
+35.96 (6.25%)
MSFT  371.98
-0.31 (-0.08%)
NVDA  181.89
+3.79 (2.13%)
ORCL  143.55
+0.38 (0.27%)
TSLA  341.88
-4.77 (-1.38%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.